Clinical Trial Update: Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV [Phase 4]

View source ↗

Summary

Phase 4 trial updating immunogenicity and safety of recombinant zoster vaccine in people living with HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Zoster Vaccination in HIV

Drugs mentioned

• Recombinant Zoster Vaccine (gZV)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Vaccination; Infection, Vaccine Adverse Reaction | Phase 4 | Status: COMPLETED